You are here
Agency Scrutinizes Attempts to Block Generics
Anti-abortionist and Republican Opposition Leads to Cancelation of Contract with Fetal Tissue Firm
Training for Pharmacists and Nurses, Not Just Prescribers
Agency To Provide $18 Million Over the Next Four Years
Two Companies Sold Unapproved Drugs on 100+ Websites
Despite Savings from Pilot Programs, Medicaid Costs Have Soared
New Draft Guidance Seeks to Better Target Patient Needs
Quality Metrics Will Provide Feedback to Manufacturers
Some see the loss of an important, unbiased source of information.
One of the proposed changes makes remote patient monitoring an allowable cost.